WOOLSEY PHARMACEUTICALS, INC.

Profile

Company Names

WOOLSEY PHARMACEUTICALS, INC.

Addresses

233 BROADWAY, SUITE 1750, NEW YORK, NY 10279

Phone Numbers

212-586-2226

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$28,255,499.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-07-30 
$19,658,498.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2020-02-18 
$8,597,001.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
M. 
GELIEBTER 
DIRECTOR, EXECUTIVE OFFICER
REMEDY PHARMACEUTICALS, INC.   |  CRITICAL CARE DIAGNOSTICS, INC.   |  WOOLSEY PHARMACEUTICALS, INC.
SVEN 
M. 
JACOBSON 
EXECUTIVE OFFICER, DIRECTOR
CRITICAL CARE DIAGNOSTICS, INC.   |  WOOLSEY PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-10-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-30 
2020-04-08
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-18 
2020-03-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#